SOCS3 and Hyperglycemia: In the liver, inactivation of hepatic SOCS3 resulted in increased insulin sensitivity and lipogenesis [28], whereas expression of recombinant STAT3 in the liver markedly attenuated hyperglycemia and hyperinsulinemia in diabetic mice [29].